CCL2 at the crossroad of cancer metastasis

Area of Science:

• Oncology
• Cancer Biology
• Molecular Biology

Background:

• Primary tumors can impair organ function through mechanical pressure or hormone production.
• Cancer patient mortality is predominantly linked to the formation of secondary growths (metastasis).
• Current research focuses on inhibiting specific steps of cancer metastasis, including cell migration, intravasation, and colonization.

Purpose of the Study:

• To highlight the clinical need for drugs targeting late-stage metastatic processes.
• To emphasize the importance of characterizing molecular targets in distinct metastasis steps.
• To support the development of novel anti-metastatic therapies.

Main Methods:

• Review of current clinical trials for anti-metastatic drugs.
• Analysis of molecular mechanisms underlying cancer metastasis.
• Identification of potential therapeutic targets in distinct metastatic phases.

Main Results:

• Metastasis, not primary tumor growth, is the main cause of cancer-related death.
• Drugs targeting cancer cell migration, intravasation, and colonization are under investigation.
• Late metastatic steps like extravasation and colonization are critical for patients with dormant micrometastases.

Conclusions:

• Targeting late metastatic processes is crucial for patients with established micrometastases.
• Further characterization of molecular targets is essential for developing effective anti-metastatic drugs.
• Developing drugs that impair distinct steps of metastasis can improve cancer patient survival rates.